Greenlane Continues Product Diversification Strategy with Additional Homeland Security and Health Safety Product Offering
Greenlane Holdings (NASDAQ:GNLN) has announced the distribution of Toxi Shield iodine tablets, manufactured by Safety Strips, Inc. These potassium iodide (KI) tablets are designed to protect the thyroid gland during radiation emergencies, such as nuclear accidents. The tablets are produced in a GMP-certified facility in the USA.
This product addition aligns with Greenlane's diversification strategy, targeting health, safety, and wellness markets. The company secured an exclusive distribution agreement with Safety Strips, Inc., enabling global shipping capabilities. The move comes amid increased nuclear safety concerns following Russia's invasion of Ukraine and growing nuclear power adoption by tech companies.
Greenlane Holdings (NASDAQ:GNLN) ha annunciato la distribuzione delle compresse di ioduro di potassio Toxi Shield, prodotte da Safety Strips, Inc. Queste compresse di ioduro di potassio (KI) sono progettate per proteggere la ghiandola tiroidea durante emergenze radioattive, come gli incidenti nucleari. Le compresse sono prodotte in una struttura certificata GMP negli Stati Uniti.
Questa aggiunta di prodotto è in linea con la strategia di diversificazione di Greenlane, mirata ai mercati della salute, della sicurezza e del benessere. L'azienda ha ottenuto un accordo di distribuzione esclusivo con Safety Strips, Inc., consentendo capacità di spedizione globale. Questa mossa avviene in un contesto di crescenti preoccupazioni per la sicurezza nucleare in seguito all'invasione dell'Ucraina da parte della Russia e all'aumento dell'adozione dell'energia nucleare da parte delle aziende tecnologiche.
Greenlane Holdings (NASDAQ:GNLN) ha anunciado la distribución de tabletas de yodo Toxi Shield, fabricadas por Safety Strips, Inc. Estas tabletas de yoduro de potasio (KI) están diseñadas para proteger la glándula tiroides durante emergencias de radiación, como accidentes nucleares. Las tabletas se producen en una instalación certificada por GMP en los Estados Unidos.
Esta adición de producto está alineada con la estrategia de diversificación de Greenlane, enfocándose en los mercados de salud, seguridad y bienestar. La compañía aseguró un acuerdo de distribución exclusivo con Safety Strips, Inc., lo que permite capacidades de envío global. Este movimiento se produce en medio de preocupaciones crecientes sobre la seguridad nuclear tras la invasión de Rusia a Ucrania y la creciente adopción de la energía nuclear por parte de empresas tecnológicas.
그린레인 홀딩스 (NASDAQ:GNLN)가 Safety Strips, Inc.에서 제작한 톡시 쉴드 요오드 정제의 배급을 발표했습니다. 이 potassium iodide (KI) 정제는 방사선 비상사태, 즉 핵사고 발생 시 갑상선을 보호하기 위해 설계되었습니다. 이 정제는 미국의 GMP 인증 시설에서 생산됩니다.
이 제품의 추가는 그린레인의 건강, 안전 및 웰빙 시장을 타겟으로 하는 다각화 전략과 일치합니다. 회사는 Safety Strips, Inc.와 독점적 배급 계약을 체결하여 글로벌 배송 능력을 갖추게 되었습니다. 이 조치는 러시아의 우크라이나 침공 이후 증가하는 핵 안전 우려와 기술 회사들의 원자력 발전 채택 증가 속에서 이루어집니다.
Greenlane Holdings (NASDAQ:GNLN) a annoncé la distribution de comprimés d'iode Toxi Shield, fabriqués par Safety Strips, Inc. Ces comprimés d'iodure de potassium (KI) sont conçus pour protéger la glande thyroïdienne lors d'urgences radiologiques, telles que les accidents nucléaires. Les comprimés sont produits dans une installation certifiée GMP aux États-Unis.
Cette addition de produit s'inscrit dans la stratégie de diversification de Greenlane, visant les marchés de la santé, de la sécurité et du bien-être. La société a obtenu un contrat de distribution exclusif avec Safety Strips, Inc., permettant des capacités d'expédition mondiales. Ce mouvement intervient dans un contexte d'inquiétude croissante concernant la sécurité nucléaire, suite à l'invasion de l'Ukraine par la Russie et à l'adoption croissante de l'énergie nucléaire par les entreprises technologiques.
Greenlane Holdings (NASDAQ:GNLN) hat die Verteilung von Toxi Shield Jodtabletten angekündigt, die von Safety Strips, Inc. hergestellt werden. Diese Kaliumiodid (KI) Tabletten sind dafür konzipiert, die Schilddrüse während Strahlennotfällen, wie zum Beispiel Nuklearunfällen, zu schützen. Die Tabletten werden in einer GMP-zertifizierten Einrichtung in den USA produziert.
Diese Produktaufnahme stimmt mit Greenslane's Diversifizierungsstrategie überein, die auf die Gesundheits-, Sicherheits- und Wellnessmärkte abzielt. Das Unternehmen hat einen exklusiven Vertriebsvertrag mit Safety Strips, Inc. gesichert, der globale Versandmöglichkeiten ermöglicht. Dieser Schritt erfolgt vor dem Hintergrund zunehmender Bedenken hinsichtlich der nuklearen Sicherheit nach der Invasion Russlands in die Ukraine und dem wachsenden Einsatz von Kernenergie durch Technologieunternehmen.
- Secured exclusive global distribution rights for Toxi Shield products
- Product expansion into health and safety market segment
- Distribution of high-margin products
- None.
Insights
The expansion into potassium iodide (KI) tablets represents a strategic pivot but raises concerns about execution and market fit. While there's growing awareness around nuclear safety preparations, particularly in Europe, this move appears disconnected from Greenlane's core competencies in cannabis accessories and vaporization products. The exclusive distribution agreement with Safety Strips offers some competitive advantage, but the market for KI tablets is highly specialized and potentially volatile.
The company's broader diversification strategy seems reactive rather than proactive, potentially diluting its brand identity and established market position. While high-margin products are attractive, success in the emergency preparedness market requires different distribution channels and marketing expertise than Greenlane's traditional business. The global shipping capability is a plus, but without disclosed pricing or margin details, it's difficult to assess the revenue potential.
This product diversification attempt appears to be a desperate move to find new revenue streams amid challenging conditions in Greenlane's core cannabis accessories market. With a micro-cap status (market cap of just
The lack of financial projections or market size estimates in the announcement is concerning. While high-margin products are mentioned, there's no concrete data on expected revenue contribution or investment required for this initiative. Given Greenlane's financial position, this diversification strategy appears more like a survival tactic than a growth opportunity.
BOCA RATON, FL / ACCESSWIRE / December 5, 2024 / Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN), one of the premier global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today announced it has begun distribution of Toxi Shield by Safety Strips' premium quality and competitively priced iodine tablets produced by Safety Strips, Inc, a portfolio company of Safe Supply Streaming Co Ltd. (CSE:SPLY)(FSE:QM4)(OTCQB:SSPLF). Potassium iodide (KI) tablets are specially designed to protect your thyroid gland in emergency situations where harmful radioactive iodine exposure is a concern and the need for a reliable short-term protection measure is recommended for use by health authorities.
KI, a non-prescription drug, does not protect against external radiation but can help protect the thyroid gland, a hormone-producing gland in the neck, from ingested or inhaled radioactive iodine that might be released into the atmosphere in a radiation emergency, such as a nuclear power plant accident. Additionally, recent directives from the Swedish and Norwegian governments include the recommendation to its citizens that they have a supply of KI tablets in the event of a nuclear accident.
"With rising fears of a potential nuclear conflict or accident after Russia's invasion of Ukraine and tech companies increasingly considering nuclear power to meet their energy needs, we believe adding the Toxi Shield product to our distribution platform is consistent with our ongoing product diversification initiative designed to offer our customers a broader array of premium health, safety and wellness products," said Barbara Sher, Chief Executive Officer for Greenlane. "We have made meaningful progress over the last six-months adding high margin products that have applications in new markets for Greenlane, where our deep customer relationships and broad distribution capabilities can drive added revenue opportunities for the company."
The Toxi Shield by Safety Strips brand of premium quality and competitively priced iodine tablets are manufactured in a Good Manufacturing Practice(GMP)-certified facility in the USA, ensuring superior quality control and adherence to industry standards. Greenlane has an exclusive distribution agreement with Safety Strips, Inc. and is also able to ship globally.
About Greenlane Holdings, Inc.
Founded in 2005, Greenlane is a premier global platform for the development and distribution of premium smoking accessories, vape devices, and lifestyle products to thousands of producers, processors, specialty retailers, smoke shops, convenience stores, and retail consumers. We operate as a powerful family of brands, third-party brand accelerator, and an omnichannel distribution platform.
We proudly offer our own diverse brand portfolio and our exclusively licensed Marley Natural and K.Haring branded products. We also offer a carefully curated set of third-party products through our direct sales channels and our proprietary, owned and operated e-commerce platforms which include Vapor.com, PuffItUp.com, HigherStandards.com, Wholesale.Greenlane.com and MarleyNaturalShop.com.
For additional information, please visit: https://investor.gnln.com. For additional information, please visit: https://gnln.com/.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning Greenlane and other matters. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expects," "plans," "anticipates," "could," "intends," "targets," "projects," "contemplates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this press release are only predictions. Greenlane has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that it believes may affect its business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. You should carefully consider the risks and uncertainties that affect our business, including those described in our filings with the Securities and Exchange Commission ("SEC"), including under the caption "Risk Factors" in Greenlane's Annual Report on Form 10-K filed for the year ended December 31, 2023 and the Company's other filings with the SEC, which can be obtained on the SEC website at www.sec.gov. These forward-looking statements speak only as of the date of this communication. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements, whether as a result of any new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our public announcements and filings with the SEC.
Investor Contact:
IR@greenlane.com
or
TraDigital IR
Kevin McGrath
+1-646-418-7002
kevin@tradigitalir.com
SOURCE: Greenlane Holdings, Inc.
View the original press release on accesswire.com
FAQ
What new product is Greenlane (GNLN) distributing in December 2023?
Does Greenlane (GNLN) have exclusive distribution rights for Toxi Shield?
Where are the Toxi Shield products distributed by Greenlane (GNLN) manufactured?
